Epirus, Ranbaxy win India approval for arthritis drug copy
September 15, 2014 at 16:08 PM EDT
Sept 15 (Reuters) - Epirus Biopharmaceuticals Inc said India's drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the country early next year.